Catalent amps up plans to manufacture J&J's Covid-19 vaccine, adding vial filling line in Italy

John Carroll

Editor & Founder

A little more than a year after Catalent CEO John Chiminski acquired Bristol Myers Squibb’s manufacturing facility in Anagni, Italy, the big CDMO is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Catalent amps up plans to manufacture J&J's Covid-19 vaccine, adding vial filling line in Italy

John Carroll

Editor & Founder

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

Catal­ent amps up plans to man­u­fac­ture J&J's Covid-19 vac­cine, adding vial fill­ing line in Italy

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Catalent amps up plans to manufacture J&J's Covid-19 vaccine, adding vial filling line in Italy